446 related articles for article (PubMed ID: 18005118)
21. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
Ohlmeier MC; Traupe H; Luger TA; Böhm M
J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of alopecia areata with diphenylcyclopropenone].
Ochsendorf FR; Mitrou G; Milbradt R
Z Hautkr; 1988 Feb; 63(2):94, 96, 99-100. PubMed ID: 3376515
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
24. Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata.
Firooz A; Bouzari N; Mojtahed F; Pazoki-Toroudi H; Nassiri-Kashani M; Davoudi M; Dowlati Y
J Eur Acad Dermatol Venereol; 2005 May; 19(3):393-4. PubMed ID: 15857483
[No Abstract] [Full Text] [Related]
25. [Therapy of alopecia areata with diphenylcyclopropenone].
Kietzmann H; Hardung H; Christophers E
Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of alopecia areata of the eyebrow with diphenylcyclopropenone and its possible risks].
Lutz G; Kreysel HW
Z Hautkr; 1989 Oct; 64(10):898-900. PubMed ID: 2588751
[TBL] [Abstract][Full Text] [Related]
28. Topical immunotherapy in the treatment of chronic severe alopecia areata.
Shapiro J
Dermatol Clin; 1993 Jul; 11(3):611-7. PubMed ID: 8365043
[TBL] [Abstract][Full Text] [Related]
29. Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone.
Wasyłyszyn T; Kozłowski W; Zabielski SL
Arch Dermatol Res; 2007 Aug; 299(5-6):231-7. PubMed ID: 17530266
[TBL] [Abstract][Full Text] [Related]
30. Topical diphencyprone immunotherapy for cutaneous metastatic melanoma.
Damian DL; Shannon KF; Saw RP; Thompson JF
Australas J Dermatol; 2009 Nov; 50(4):266-71. PubMed ID: 19916970
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata.
Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682
[TBL] [Abstract][Full Text] [Related]
32. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
Inui S; Nakajima T; Toda N; Itami S
J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
[TBL] [Abstract][Full Text] [Related]
33. Alopecia areata treatment with a phototoxic dose of UVA and topical 8-methoxypsoralen.
Mohamed Z; Bhouri A; Jallouli A; Fazaa B; Kamoun MR; Mokhtar I
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):552-5. PubMed ID: 16164707
[TBL] [Abstract][Full Text] [Related]
34. Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata.
Pazoki-Toroudi H; Ajami M; Babakoohi S; Khaki L; Habibey R; Akhiani M; Seirafi H; Firooz A
Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):422-5. PubMed ID: 20095801
[TBL] [Abstract][Full Text] [Related]
35. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
Katagiri K; Arakawa S; Hatano Y; Fujiwara S
J Dermatol; 2006 Feb; 33(2):75-9. PubMed ID: 16556272
[TBL] [Abstract][Full Text] [Related]
36. Topical immunotherapy of alopecia areata.
van der Steen PH; Happle R
Dermatol Clin; 1993 Jul; 11(3):619-22. PubMed ID: 8365044
[TBL] [Abstract][Full Text] [Related]
37. [Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients].
Assouly P; Reygagne P; Jouanique C; Matard B; Marechal E; Reynert P; Bachelez H; Dubertret L
Ann Dermatol Venereol; 2003 Mar; 130(3):326-30. PubMed ID: 12746668
[TBL] [Abstract][Full Text] [Related]
38. Topical immunotherapy changes the composition of the peribulbar infiltrate in alopecia areata.
Happle R; Klein HM; Macher E
Arch Dermatol Res; 1986; 278(3):214-8. PubMed ID: 2873796
[TBL] [Abstract][Full Text] [Related]
39. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
[TBL] [Abstract][Full Text] [Related]
40. Treatment of alopecia areata with squaric acid dibutylester.
Caserio RJ
Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]